Marksans Pharma raises Rs 372.40 crore in equity via conversion of warrants issued to OrbiMed and…
The warrants are converted at a price of Rs 74 per share, reflecting the promoter's and OrbiMed's commitment to the company
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.